药品名称DOBUTREX
申请号017820产品号002
活性成分DOBUTAMINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格EQ 12.5MG BASE/ML
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ELI LILLY AND CO
化学类型New molecular entity (NME)审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
017820037APLetter2002/07/23下载
017820037APReview2002/07/23下载
017820036APReview1998/07/29下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
017820037AP2002/07/23Labeling Revision
017820036AP1998/07/29Labeling Revision
017820034AP1997/01/08Control Supplement
017820033AP1996/03/06Labeling Revision
017820032AP1995/11/09Manufacturing Change or Addition
017820031AP1996/01/11Control Supplement
017820030AP1995/03/10Manufacturing Change or Addition
017820029AP1995/03/30Labeling Revision
017820027AP1994/04/20Labeling Revision
017820026AP1993/02/09Control Supplement
017820025AP1993/02/01Control Supplement
017820024AP1990/12/20Labeling Revision
017820023AP1991/04/26Labeling Revision
017820022AP1989/12/07Labeling Revision
017820021AP1989/04/18Labeling Revision
017820020AP1989/06/23Labeling Revision
017820019AP1988/04/21Labeling Revision
017820018AP1987/05/27Labeling Revision
017820017AP1987/01/21Control Supplement
017820016AP1987/05/27Labeling Revision
017820015AP1987/01/21Labeling Revision
017820013AP1986/03/07Manufacturing Change or Addition
017820011AP1986/03/07Control Supplement
017820010AP1985/07/25Control Supplement
017820008AP1983/06/24Formulation Revision
017820007AP1982/02/24Control Supplement
017820006AP1986/09/08Labeling Revision
017820005AP1981/06/17Manufacturing Change or Addition
017820004AP1981/02/03Control Supplement
017820003AP1980/08/13Control Supplement
017820002AP1978/09/12Expiration Date Change
017820001AP1978/09/12Labeling Revision
017820000AP1978/07/18Approval